Clinical trial
A Randomized Phase III, Multicentre, Open Label Clinical Trial Comparing Azacitidine Plus Pevonedistat Versus Azacitidine in Older/Unfit Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Chemotherapy
NCT04090736 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase III, Multicentre, Open Label Clinical Trial Comparing Azacitidine Plus Pevonedistat Versus Azacitidine in Older/Unfit Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Chemotherapy
- Lead sponsor
- PETHEMA Foundation
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- September 24, 2019
- Completion date
- July 30, 2026
- Enrollment
- 302 (actual)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.